When Will Pfizer Be Ready For Its Next Big (Or Small) Move?
This article was originally published in The Pink Sheet Daily
Executive Summary
A year after its failed takeover bid for AstraZeneca, Pfizer Inc. continues to face questions about whether it will pursue another large-scale merger, and how it is preparing for a potential spin off.